We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Myomo Inc (MYO) USD0.0001

Sell:$2.72 Buy:$2.76 Change: $0.11 (3.85%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.11 (3.85%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.11 (3.85%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Myomo, Inc. is a wearable medical robotics company. The Company offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The Company develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. It primarily provides devices directly to patients and bills their insurance companies.

Contact details

137 Portland Street, 4Th Floor
United States
+1 (617) 9969058

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$79.71 million
Shares in issue:
27.87 million
Health Care Equipment
United States
US dollar

Key personnel

  • Paul Gudonis
    Chairman of the Board, President, Chief Executive Officer
  • David Henry
    Chief Financial Officer
  • Harry Kovelman
    Chief Medical Officer
  • Micah Mitchell
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.